HC Wainwright Forecasts Geron’s Q3 Earnings (NASDAQ:GERN)
Geron Co. (NASDAQ:GERN – Free Report) – Investment analysts at HC Wainwright reduced their Q3 2025 EPS estimates for shares of Geron in a research report issued to clients and investors on Wednesday, May 7th. HC Wainwright analyst E. Bodnar now anticipates that the biopharmaceutical company will post earnings of ($0.03) per share for the […]
